Appello Pharmaceuticals is a clinical-stage neurology company, currently advancing its lead compound for the treatment of Parkinson’s disease.

Biotechnology

Appello Pharmaceuticals

Appello Pharmaceuticals' headquarters in Nashville, TN, United States

Brian Laden

Robert Elfont

Howie Furst

P. Jeffrey Conn

Vaughn Bryson

Bill Slattery

Craig Lindsley

Joann Scatina

Joe Cook Jr

The Nonclinical Development team at Appello Pharmaceuticals designs and executes preclinical studies to evaluate the safety and efficacy of lead compounds. They collaborate closely on strategic planning and toxicological assessments to support clinical trial readiness and regulatory submissions for treatments targeting Parkinson's disease.

Nonclinical Development

The Leadership Team at Appello Pharmaceuticals is responsible for setting the strategic direction and ensuring the successful advancement of the company's clinical programs, particularly in the treatment of Parkinson's disease. This team, composed of key executives such as the President & CEO and Chief Medical Officer, collaborates to drive clinical development, oversee regulatory compliance, and foster partnerships that enhance the company's mission to innovate in neurology.

��

Appello Pharmaceuticals

Org chart

Board & advisors

Teams

Nonclinical Development

Leadership Team

Offices

��������

Appello Pharmaceuticals

Org chart

Board & advisors

Teams

Nonclinical Development

Leadership Team

Offices

Related companies

��